Clinical trial
The Assessment of the Plaque at RISK by Non-invasive (Molecular) Imaging and Modelling (ParisK): Prospective Clinical Study for Diagnosis Efficacy for High Risk Plaque and Stroke.
NCT01208025 is registered in ClinicalTrials.gov with Maastricht University Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Assessment of the Plaque at RISK by Non-invasive (Molecular) Imaging and Modelling (ParisK): Prospective Clinical Study for Diagnosis Efficacy for High Risk Plaque and Stroke.
- Lead sponsor
- Maastricht University Medical Center
- Phase
- Observational
- Overall status
- Completed
- Start date
- September 30, 2010
- Completion date
- December 31, 2016
- Enrollment
- 244 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.